Excessive daytime sleepiness and narcolepsy - An approach to investigation and management

European Journal of Internal Medicine

Volumn 23, Issue 2, 2012, Pages 110-117

  Morrison, Ian ^a   Riha, Renata L ^b  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Excessive daytime sleepiness; Hypersomnia; Investigation of sleepiness; Narcolepsy review; Treatment of narcolepsy and cataplexy

Indexed keywords

AMPHETAMINE DERIVATIVE; METHYLPHENIDATE; MODAFINIL; OREXIN; OXYBATE SODIUM; PEMOLINE; REBOXETINE; RITANSERIN; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CATAPLEXY; CLINICAL FEATURE; DAYTIME SOMNOLENCE; DIFFERENTIAL DIAGNOSIS; DRUG MECHANISM; EPWORTH SLEEPINESS SCALE; EXCESSIVE DAYTIME SLEEPINESS; HUMAN; IMMUNE SYSTEM; MULTIPLE SLEEP LATENCY TEST; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NARCOLEPSY; NONHUMAN; PATHOGENESIS; POLYSOMNOGRAPHY; REVIEW;

EID: 84856423241     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.09.005     Document Type: Short Survey

References (83)

1. International Classification of Sleep Disorders, 2nd Ed, Diagnostic and Coding Manual. Westchester, IL: American Academy of Sleep Medicine 2006.
2. M.S. Wise, D.L. Arand, R.R. Auger, S.N. Brooks, and N.F. Watson Treatment of narcolepsy and other hypersomnias of central origin Sleep 30 2007 1712 1727
3. C.L. Hart, M. Haney, S.K. Vosburg, S.D. Comer, E. Gunderson, and R.W. Foltin Modafinil attenuates disruptions in cognitive performance during simulated night-shift work Neuropsychopharmacology 31 2006 1526 1536
4. T.E. Weaver, and N. Cuellar A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy Sleep 29 2006 1189 1194 (Pubitemid 44484812)
5. C. Hublin, J. Kaprio, M. Partinen, K. Heikkila, and M. Koskenvuo Daytime sleepiness in an adult, Finnish population J Intern Med 239 1996 417 423 (Pubitemid 26246423)
6. P. Lavie Sleep habits and sleep disturbances in industrial workers in Israel: main findings and some characteristics of workers complaining of excessive daytime sleepiness Sleep 4 1981 147 158 (Pubitemid 11065812)
7. K. Martikainen, J. Hasan, H. Urponen, I. Vuori, and M. Partinen Daytime sleepiness: a risk factor in community life Acta Neurol Scand 86 1992 337 341
8. M.M. Ohayon From wakefulness to excessive sleepiness: what we know and still need to know Sleep Med Rev 12 2008 129 141 (Pubitemid 351374843)
9. M.W. Johns A new method for measuring daytime sleepiness: the Epworth sleepiness scale Sleep 14 1991 540 545
10. R.B. Sangal, M.M. Mitler, and J.M. Sangal Subjective sleepiness ratings (Epworth sleepiness scale) do not reflect the same parameter of sleepiness as objective sleepiness (maintenance of wakefulness test) in patients with narcolepsy Clin Neurophysiol 110 1999 2131 2135 (Pubitemid 29528410)
11. N. Tachibana, and M. Taniguchi Why do we continue to use Epworth sleepiness scale?[letter] Sleep Med 8 2007 541 542 (Pubitemid 46971993)
12. M.J. Thorpy The clinical use of the Multiple Sleep Latency Test. The standards of practice committee of the American Sleep Disorders Association Sleep 15 1992 268 276
13. M.S. Aldrich, R.D. Chervin, and B.A. Malow Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy Sleep 20 1997 620 629 (Pubitemid 27449600)
14. R.L. Riha, A. Poddar, G. Doyle, T.W. Mackay, and N.J. Douglas Multiple sleep latency testing in the United Kingdom and Europe (poster presentation) European Respiratory Society Annual Congress 2006
15. I. Morrison, J. Buskova, S. Nevsimalova, N.J. Douglas, and R.L. Riha Diagnosing narcolepsy with cataplexy on history alone: challenging the International Classification of Sleep Disorders (ICSD-2) criteria Eur J Neurol 18 2011 1017 1020
16. E. Mignot Genetic and familial aspects of narcolepsy Neurology 50 1998 S16 S22
17. Y. Oka, Y. Inoue, T. Kanbayashi, K. Kuroda, M. Miyamoto, and T. Miyamoto Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings Sleep 29 2006 1439 1443 (Pubitemid 44764669)
18. S. Knudsen, P.J. Jennum, J. Alving, S.P. Sheikh, and S. Gammeltoft Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population Sleep 33 2010 169 176
19. C. Hublin, M. Partinen, J. Kaprio, M. Koskenvuo, and C. Guilleminault Epidemiology of narcolepsy Sleep 17 1994 S7 S12
20. W.T.J. Longstreth, T.D. Koepsell, T.G. Ton, A.F. Hendrickson, and G. van Belle The epidemiology of narcolepsy Sleep 30 2007 13 26 (Pubitemid 46098865)
21. M.M. Ohayon, R.G. Priest, J. Zulley, S. Smirne, and T. Paiva Prevalence of narcolepsy symptomatology and diagnosis in the European general population Neurology 58 2002 1826 1833 (Pubitemid 34663586)
22. Y. Dauvilliers, J. Montplaisir, N. Molinari, B. Carlander, B. Ondze, and A. Besset Age at onset of narcolepsy in two large populations of patients in France and Quebec Neurology 57 2001 2029 2033 (Pubitemid 33126870)
23. C.H. Schenck, and M.W. Mahowald Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder Ann Neurol 32 1992 3 10
24. S. Nightingale, J.C. Orgill, I.O. Ebrahim, S.F. de Lacy, S. Agrawal, and A.J. Williams The association between narcolepsy and REM behavior disorder (RBD) Sleep Med 6 2005 253 258 (Pubitemid 40613536)
25. S. Overeem, E. Mignot, J.G. van Dijk, and G.J. Lammers Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives J Clin Neurophysiol 18 2001 78 105 (Pubitemid 32549906)
26. Y. Honda, Y. Doi, R. Ninomiya, and C. Ninomiya Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients Sleep 9 1986 254 259 (Pubitemid 18008505)
27. A. Schuld, J. Hebebrand, F. Geller, and T. Pollmacher Increased body-mass index in patients with narcolepsy Lancet 355 2000 1274 1275 (Pubitemid 30184546)
28. G.J. Lammers, H. Pijl, J. Iestra, J.A. Langius, G. Buunk, and A.E. Meinders Spontaneous food choice in narcolepsy.[letter] Sleep 19 1996 75 76
29. G. Mayer, F. Hellmann, E. Leonhard, and K. Meier-Ewert Circadian temperature and activity rhythms in unmedicated narcoleptic patients Pharmacol Biochem Behav 58 1997 395 402 (Pubitemid 27394291)
30. S. Nishino, B. Ripley, and S. Overeem Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy Ann Neurol 50 2001 381 388 (Pubitemid 32848741)
31. F. Poli, G. Plazzi, and G. Di Dalmazi Body mass index-independent metabolic alterations in narcolepsy with cataplexy Sleep 32 2009 1491 1497
32. E. Mignot, C. Wang, and C. Rattazzi Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment Proc Natl Acad Sci USA 88 1991 3475 3478 (Pubitemid 21916644)
33. L. Lin, J. Faraco, and R. Li The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene Cell 98 1999 365 376 (Pubitemid 29380571)
34. B. Ripley, S. Overeem, and N. Fujiki CSF hypocretin/orexin levels in narcolepsy and other neurological conditions Neurology 57 2001 2253 2258 (Pubitemid 34016460)
35. L. de Lecea, T.S. Kilduff, and C. Peyron The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity Proc Natl Acad Sci USA 95 1998 322 327 (Pubitemid 28103952)
36. N. Tsujino, and T. Sakurai Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system Pharmacol Rev 61 2009 162 176
37. Billiard M. Narcolepsy Clinical features and aetiology Ann Clin Res 17 1985 220 226
38. C. Peyron, J. Faraco, and W. Rogers A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains Nat Med 6 2000 991 997
39. Z. Pelin, C. Guilleminault, N. Risch, F.C. Grumet, and E. Mignot HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group Tissue Antigens 51 1998 96 100 (Pubitemid 28014550)
40. E. Mignot, L. Lin, and W. Rogers Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups Am J Hum Genet 68 2001 686 699 (Pubitemid 32202763)
41. E. Mignot, R. Hayduk, J. Black, F.C. Grumet, and C. Guilleminault HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients Sleep 20 1997 1012 1020 (Pubitemid 28042450)
42. T. Kanbayashi, A. Goto, and Y. Hishikawa Hypersomnia due to acute disseminated encephalomyelitis in a 5-year-old girl Sleep Med 2 2001 347 350 (Pubitemid 32677409)
43. M.S. Aldrich, and M.W. Naylor Narcolepsy associated with lesions of the diencephalon Neurology 39 1989 1505 1508 (Pubitemid 19286011)
44. R.F. Gledhill, P.R. Bartel, Y. Yoshida, S. Nishino, and T.E. Scammell Narcolepsy caused by acute disseminated encephalomyelitis Arch Neurol 61 2004 758 760 (Pubitemid 38637695)
45. H. Schrader, O.B. Gotlibsen, and G.N. Skomedal Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin Neurology 30 1980 105 108 (Pubitemid 10160227)
46. V. Cvetkovic-Lopes, L. Bayer, and S. Dorsaz Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients J Clin Invest 120 2010 713 719
47. J. Hallmayer, J. Faraco, and L. Lin Narcolepsy is strongly associated with the T-cell receptor alpha locus Nat Genet 41 2009 708 711
48. A. Aran, L. Lin, and S. Nevsimalova Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset Sleep 32 2009 979 983
49. R. Fronczek, J. Verschuuren, and G.J. Lammers Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy J Neurol 254 2007 1607 1608 (Pubitemid 350159905)
50. P.O. Valko, R. Khatami, C.R. Baumann, and C.L. Bassetti No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy J Neurol 255 2008 1900 1903
51. Y. Dauvilliers, B. Abril, E. Mas, F. Michel, and M. Tafti Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment Neurology 73 2009 1333 1334
52. S. Overeem, J.L.R. Black, and G.J. Lammers Narcolepsy: immunological aspects Sleep Med Rev 12 2008 95 107
53. T.I. Morgenthaler, V.K. Kapur, and T. Brown Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin Sleep 30 2007 1705 1711 (Pubitemid 350234749)
54. M. Billiard, C. Bassetti, and Y. Dauvilliers EFNS guidelines on management of narcolepsy Eur J Neurol 13 2006 1035 1048 (Pubitemid 44434309)
55. A. Moscovitch, M. Partinen, and C. Guilleminault The positive diagnosis of narcolepsy and narcolepsy's borderland Neurology 43 1993 55 60 (Pubitemid 23035357)
56. E. Mignot, G.J. Lammers, and B. Ripley The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias Arch Neurol 59 2002 1553 1562
57. M.S. Aldrich The neurobiology of narcolepsy-cataplexy Prog Neurobiol 41 1993 533 541
58. J.R. Schwartz, N.T. Feldman, and R.K. Bogan Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness J Neuropsychiatry Clin Neurosci 17 2005 405 412 (Pubitemid 46179305)
59. J.R. Schwartz, M.T. Nelson, E.R. Schwartz, and R.J. Hughes Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness Clin Neuropharmacol 27 2004 74 79 (Pubitemid 38569178)
60. J.R. Schwartz, N.T. Feldman, R.K. Bogan, M.T. Nelson, and R.J. Hughes Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy Clin Neuropharmacol 26 2003 252 257 (Pubitemid 37221636)
61. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy Sleep 25 2002 42 49
62. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy J Clin Sleep Med 1 2005 391 397
63. J.S. Ballon, and D. Feifel A systematic review of modafinil: potential clinical uses and mechanisms of action J Clin Psychiatry 67 2006 554 566 (Pubitemid 43764232)
64. T.M. Korotkova, B.P. Klyuch, A.A. Ponomarenko, J.S. Lin, H.L. Haas, and O.A. Sergeeva Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors Neuropharmacology 52 2007 626 633 (Pubitemid 46137978)
65. J.S. Lin, B. Roussel, H. Akaoka, P. Fort, G. Debilly, and M. Jouvet Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat Brain Res 591 1992 319 326
66. J.S. Lin, Y. Hou, and M. Jouvet Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat Proc Natl Acad Sci USA 93 1996 14128 14133 (Pubitemid 26424257)
67. T. Gallopin, P.H. Luppi, F.A. Rambert, A. Frydman, and P. Fort Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study Sleep 27 2004 19 25 (Pubitemid 43906308)
68. C.B. Saper, and T.E. Scammell Modafinil: a drug in search of a mechanism Sleep 27 2004 11 12 (Pubitemid 43906305)
69. British National Formulary www.bnf.org 2007
70. European Medicines Agency. Press release. 2010.
71. H. Bastuji, and M. Jouvet Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil Prog Neuropsychopharmacol Biol Psychiatry 12 1988 695 700
72. A.L. Pelissier-Alicot, M.D. Piercecchi-Marti, and C. Bartoli Abusive prescription of psychostimulants: a study of two cases J Forensic Sci 51 2006 407 410 (Pubitemid 43382090)
73. H. Nissbrandt, and G. Engberg The GABAB-receptor antagonist, CGP 35348, antagonises gamma-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice J Neural Transm 103 1996 1255 1263 (Pubitemid 26413280)
74. Y. Itzhak, and S.F. Ali Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB Ann N Y Acad Sci 965 2002 451 460 (Pubitemid 34721992)
75. M.A. Carai, G. Colombo, and R. Reali Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid Eur J Pharmacol 441 2002 157 163 (Pubitemid 34626166)
76. T. Bottiglieri Effect of gamma-hydroxybutyrate on locomotor activity and brain dopamine metabolism in the rat J Neurosci Abstr 27 2001 971
77. C.F. George, N. Feldman, and N. Inhaber A safety trial of sodium oxybate in patients with obstructive sleep apnea: acute effects on sleep-disordered breathing Sleep Med 2009
78. D.D. Han, and H.H. Gu Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs BMC Pharmacol 6 2006 6
79. J.M. Fry Treatment modalities for narcolepsy Neurology 50 1998 S43 S48
80. C.W. Berridge, D.M. Devilbiss, and M.E. Andrzejewski Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function Biol Psychiatry 60 2006 1111 1120 (Pubitemid 44647216)
81. M. Prinzmetal, and BW The use of benzedrine for the treatment of narcolepsy J Am Med Assoc 105 1935 2051 2054
82. A.E. Fleckenstein, T.J. Volz, E.L. Riddle, J.W. Gibb, and G.R. Hanson New insights into the mechanism of action of amphetamines Annu Rev Pharmacol Toxicol 47 2007 681 698
83. L. Vignatelli, R. D'Alessandro, and L. Candelise Antidepressant drugs for narcolepsy Cochrane Database Syst Rev 2008 CD003724